ArticleCurrent oncology (Toronto, Ont.)2022

Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization.

Rebekah Rittberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.